We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · August 01, 2019

Predictors of Response to Immune Checkpoint Inhibitors in Patients With Advanced Esophagogastric Cancer

Clinical Cancer Research

 

Additional Info

Clinical Cancer Research
Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients With Advanced Esophagogastric Cancer
Clin. Cancer Res 2019 Jul 23;[EPub Ahead of Print], M Greally, JF Chou, WK Chatila, M Margolis, M Capanu, JF Hechtman, Y Tuvy, R Kundra, F Daian, M Ladanyi, DP Kelsen, DH Ilson, MF Berger, LH Tang, DB Solit, LA Diaz, N Schultz, YY Janjigian, GY Ku

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading